Literature DB >> 28831599

Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease.

Xin-Xin Cao1, Na Niu2, Jian Sun3, Dao-Bin Zhou1, Jian Li4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28831599     DOI： 10.1007/s00277-017-3114-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Bone mineral density and bone microarchitecture in a cohort of patients with Erdheim-Chester Disease.

Authors:  Tianhua He; Lijia Cui; Na Niu; Fengdan Wang; Huilei Miao; Hao Zhao; Xuemin Gao; Chang Liu; Fan Yu; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Daobin Zhou; Jian Li; Xinxin Cao; Weibo Xia
Journal:  Orphanet J Rare Dis       Date:  2020-09-04       Impact factor: 4.123

2.  Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.

Authors:  Ting Liu; Hua-Cong Cai; Hao Cai; Miao Chen; Wei Zhang; Jian Li; Dao-Bin Zhou; Xin-Xin Cao
Journal:  Orphanet J Rare Dis       Date:  2022-02-07       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.